Absci Corp (ABSI)
4.25
+0.04
(+0.95%)
USD |
NASDAQ |
May 28, 16:00
4.36
+0.11
(+2.59%)
After-Hours: 20:00
Absci Total Long Term Debt (Quarterly): 7.046M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.046M |
| December 31, 2023 | 7.918M |
| September 30, 2023 | 8.762M |
| June 30, 2023 | 9.523M |
| March 31, 2023 | 10.27M |
| December 31, 2022 | 10.93M |
| September 30, 2022 | 8.871M |
| June 30, 2022 | 9.26M |
| March 31, 2022 | 2.931M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.524M |
| September 30, 2021 | 4.112M |
| June 30, 2021 | 155.04M |
| March 31, 2021 | 130.06M |
| December 31, 2020 | 5.676M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
155.04M
Maximum
Jun 2021
21.99M
Average
7.918M
Median
Dec 2023
Total Long Term Debt (Quarterly) Benchmarks
| Eli Lilly and Co | 26.21B |
| Creative Medical Technology Holdings Inc | -- |
| CytomX Therapeutics Inc | 0.00 |
| HOOKIPA Pharma Inc | 1.144M |
| Recursion Pharmaceuticals Inc | 1.126M |